Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001628280-26-019266

EVP, Chief R&D Officer gave up 1,629 shares (to pay taxes)

  • EVP, Chief R&D Officer acquired 19,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Friberg Gregory R · EVP, Chief R&D Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-16 Grant or award : show line 1 in the form +19,150 56,728 D
2026-03-17 Shares withheld for taxes : show line 2 in the form −1,629 $56.05 $91,305 55,099 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-16 Grant or award : show line 3 in the form Stock Option (Right to Buy Common Stock) +45,600 45,600 D
Loading xslF345X06/wk-form4_1773855579.xml…